BioSpace News Archive

- ADDF’s Diagnostics Accelerator partners with leading pharmaceutical companies to provide access to valuable patient samples collected from earlier clinical trials to qualified researchers for biomarker development - ADDF also announces three new research awards, expanding the Diagnostics Accelerator’s investments to almost $16 million across the world [22-July-2020]

Nuvem Health (“Nuvem” or the “Company”), a high-growth, healthcare technology company offering pharmacy claims administration and related analytics solutions to safety net healthcare providers, announced the completion of a recapitalization transaction with Parthenon Capital (“Parthenon”), a growth-oriented private equity firm

Kubota Vision Inc. (Kubota Vision), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced that the company and The Research Foundation for the State University of New York (Foundation) have entered into a research agreement to conduct and carry out the testing and characterization of our investigational, wearable myopia-control device based on

Fresenius Kabi USA is voluntarily recalling two lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg/50 mL (4 mcg / mL), 50 mL fill in a 50 mL vial.

There is a direct link between the COVID-19 virus and acute respiratory distress syndrome (ARDS) in COVID-19 patients.

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter ended June 30, 2020, after the close of market on Wednesday, July 29, 2020.

Updated COVID-19 projections released by PolicyLab at Children’s Hospital of Philadelphia show communities across the Northeast are struggling to fend off risk for virus resurgence as the south continues to experience significant growth in cases.

Syapse®, a real-world data company accelerating the delivery of precision medicine through the Syapse Learning Health Network™, announced results based on real-world data that were highlighted at the AACR Virtual Meeting on COVID-19 and Cancer.

SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release second quarter financial results after the close of trading on Tuesday, August 4, 2020.

Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, announced today the results from two primary market research studies of clinicians who treat osteoporosis patients.